GeneDx Holdings Corp.

WGS

Precision medicineHealthcare diagnosticsGenomic analysis

$86.06vs prev close▼-1.01(-1.15%)

$32.2152W Range$170.87

39% from low

+27.97 (+47.33%)Past 1M

Price

ARK Trade PatternPREMIUM

1M Trades

3 buys

Concentrated buys

1M net buy

+$11.4M

≈ +163K shares

Portfolio Weight

0.82%

1M +0.13%p

Holding ETFs

2 ETFs

ARKG · ARKK

Buy · Weight Up

ARK net-bought the stock and the price rose, increasing its portfolio weight.

Shares +6.3% · Market value +7.8% · Weight +0.13%p

Trade Intensity

Concentrated buys

Basis: 0 sells · 3 buys in 1M · Multi-ETF simultaneous buy · weight +0.13%p increase

Trade Log3-day BUY streak

Date	Action	ETF	Shares	Close	Est. total
26.08.06	BUY	ARKG · ARKK	32,194	$69.59	$2.2M
26.08.05	BUY	ARKG · ARKK	57,019	$69.91	$4.0M
26.08.04	BUY	ARKG · ARKK	73,368	$70.90	$5.2M
26.06.11	SELL	ARKK	87,006	$60.99	$5.3M
26.05.05	BUY	ARKG · ARKK	245,914	$34.51	$8.5M
26.04.09	BUY	ARKG · ARKK	32,767	$60.05	$2.0M
26.04.08	BUY	ARKG · ARKK	12,516	$65.59	$820.9K
26.04.07	BUY	ARKG · ARKK	4,121	$66.89	$275.7K
26.04.02	BUY	ARKG · ARKK	2,869	$66.20	$189.9K
26.04.01	BUY	ARKG · ARKK	11,105	$65.52	$727.6K
26.03.31	BUY	ARKG · ARKK	4,559	$64.22	$292.8K
26.03.30	BUY	ARKG · ARKK	20,674	$59.61	$1.2M
26.03.13	BUY	ARKG · ARKK	6,017	$77.78	$468.0K
26.03.12	BUY	ARKG · ARKK	52,075	$76.85	$4.0M
26.03.11	BUY	ARKG · ARKK	2,822	$85.10	$240.2K

08.06BUY

32,194

ARKG · ARKKClose$69.59Est. total$2.2M

08.05BUY

57,019

ARKG · ARKKClose$69.91Est. total$4.0M

08.04BUY

73,368

ARKG · ARKKClose$70.90Est. total$5.2M

06.11SELL

87,006

ARKKClose$60.99Est. total$5.3M

05.05BUY

245,914

ARKG · ARKKClose$34.51Est. total$8.5M

04.09BUY

32,767

ARKG · ARKKClose$60.05Est. total$2.0M

04.08BUY

12,516

ARKG · ARKKClose$65.59Est. total$820.9K

04.07BUY

4,121

ARKG · ARKKClose$66.89Est. total$275.7K

04.02BUY

2,869

ARKG · ARKKClose$66.20Est. total$189.9K

04.01BUY

11,105

ARKG · ARKKClose$65.52Est. total$727.6K

03.31BUY

4,559

ARKG · ARKKClose$64.22Est. total$292.8K

03.30BUY

20,674

ARKG · ARKKClose$59.61Est. total$1.2M

03.13BUY

6,017

ARKG · ARKKClose$77.78Est. total$468.0K

03.12BUY

52,075

ARKG · ARKKClose$76.85Est. total$4.0M

03.11BUY

2,822

ARKG · ARKKClose$85.10Est. total$240.2K

1 / 3

Prices estimated from market closing prices on trade dates. Actual execution prices may differ. This is not investment advice.

Stock Timeline

Institutional Holders

1 Holding · 0 Sold · Q4 2025

Based on ARK ETF real-time + 13F quarterly filings

Cathie WoodARK Invest

LIVE

1,451,000

Portfolio Weight

0.82%

in ETF 2.05%

Est. Value

$101M

30D Net

+$11M

13F data may be delayed up to 90 days.

Market Context

Analyst Consensus

※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.

Overall Opinion

Strong Buy

Buy

Analyst Targets

avg.

$90.44

vs Current ▲ +3.9% upside

Current$87.06

Low ~ High$74.00 ~ $103.00

Firm

Position

Price Target

Upside / Downside

Close Price

Action

Date

Canaccord Genuity

Buy

$90.00

+3.38%

—

Maintain

2026-08-04

BTIG

Buy

$90.00

+3.38%

—

Maintain

2026-08-04

Guggenheim

Buy

$74.00

-15.00%

—

Maintain

2026-06-29

Piper Sandler

Overweight

$63.00

-27.64%

—

Maintain

2026-06-23

Canaccord Genuity

Buy

$75.00

-13.85%

—

Maintain

2026-05-05

1 / 4

Avg Target

$90.44

vs Current ▲ +3.9% upside

Strong Buy

9 analysts

Strong Buy 1Buy 8

Low $74.00

Current $87.06

High $103.00

Firm	Position	Target	Upside	Close	Action	Date
Canaccord Genuity	Buy	$90.00	+3.38%	—	Maintain	26.08.04
BTIG	Buy	$90.00	+3.38%	—	Maintain	26.08.04
Guggenheim	Buy	$74.00	-15.00%	—	Maintain	26.06.29
Piper Sandler	Overweight	$63.00	-27.64%	—	Maintain	26.06.23
Canaccord Genuity	Buy	$75.00	-13.85%	—	Maintain	26.05.05

1 / 4

Price Information

Previous Close$82.55

Open$83.19

Day Range$80.76 - $87.17

52-Week Range$32.21 - $170.87

1-Year Change-28.56%

Trading Volume

Volume555,184

Avg Volume (3mo)908,766

Valuation

Market Cap2.6B

Book Value$8.57

Shares Outstanding29,822,541

Financials

Revenue (TTM)454.4M

Net Income-106,357,000

EPS$-3.63

EBITDA-33,695,000

Profitability

P/E Ratio-

P/B Ratio10.16

Return on Equity (ROE)-40.80%

Return on Assets (ROA)-7.89%

Profit Margin-23.41%

EV/EBITDA-78.09

Beta1.98

Dividend

Dividend Rate-

Dividend Yield-

Technical

RSI(14)78.31

Company Overview

GeneDx Holdings Corp. is a genomics company specializing in genetic testing services for pediatric and rare diseases. Their main offerings include whole exome and genome sequencing, alongside data and information services, and an AI-powered platform for analyzing next-generation sequencing data. GeneDx aims to improve diagnostics and reporting for hereditary conditions and cancer.

P/B

10.16

High valuation

ROE

-40.8%

Persistent loss

Beta

1.98

High volatility

RSI(14)

78.3

Overbought

AI-generated summary. Not investment advice.

GeneDx Holdings Corp.

Analyst Consensus

Price Information

Trading Volume

Valuation

Financials

Profitability

Dividend

Technical

Related ARK stocks